Jason M. Gow

825 total citations
12 papers, 615 citations indexed

About

Jason M. Gow is a scholar working on Oncology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jason M. Gow has authored 12 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Infectious Diseases and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jason M. Gow's work include Drug Transport and Resistance Mechanisms (7 papers), HIV/AIDS drug development and treatment (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Jason M. Gow is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), HIV/AIDS drug development and treatment (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Jason M. Gow collaborates with scholars based in United States and United Kingdom. Jason M. Gow's co-authors include Deanna L. Kroetz, Leslie W. Chinn, Laura M. Hodges, Russ B. Altman, Teri E. Klein, Svetlana Markova, Jon C. Mirsalis, Anna Furimsky, Dennis E. Kyle and Lalitha Iyer and has published in prestigious journals such as Pharmacological Reviews, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jason M. Gow

12 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason M. Gow United States	11	266	157	140	103	92	12	615
King Leung Fung United States	10	349 1.3×	204 1.3×	104 0.7×	53 0.5×	68 0.7×	13	608
Henrike Bruckmueller Germany	16	241 0.9×	194 1.2×	109 0.8×	126 1.2×	47 0.5×	25	600
Marius Dohse Germany	9	497 1.9×	230 1.5×	157 1.1×	40 0.4×	93 1.0×	13	788
Taiji Sawamoto Japan	17	159 0.6×	100 0.6×	59 0.4×	51 0.5×	101 1.1×	30	644
Heike Lindenmaier Germany	10	397 1.5×	173 1.1×	229 1.6×	75 0.7×	187 2.0×	11	734
Svetlana Markova United States	3	196 0.7×	122 0.8×	94 0.7×	98 1.0×	40 0.4×	6	416
Guillermo F. Bramuglia Argentina	17	295 1.1×	187 1.2×	111 0.8×	31 0.3×	56 0.6×	48	913
T Fujitsu Japan	10	99 0.4×	128 0.8×	114 0.8×	35 0.3×	55 0.6×	18	625
J.H.M. Schellens Netherlands	10	378 1.4×	141 0.9×	118 0.8×	86 0.8×	32 0.3×	15	528

Countries citing papers authored by Jason M. Gow

Since Specialization

Citations

This map shows the geographic impact of Jason M. Gow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason M. Gow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason M. Gow more than expected).

Fields of papers citing papers by Jason M. Gow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason M. Gow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason M. Gow. The network helps show where Jason M. Gow may publish in the future.

Co-authorship network of co-authors of Jason M. Gow

This figure shows the co-authorship network connecting the top 25 collaborators of Jason M. Gow. A scholar is included among the top collaborators of Jason M. Gow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason M. Gow. Jason M. Gow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Gow, Jason M., Wayne Tsuji, Gary J. Williams, et al.. (2015). Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects. Arthritis Research & Therapy. 17(1). 282–282. 22 indexed citations

Stock, Howard S., et al.. (2015). Tenofovir Disoproxil Fumarate. International Journal of Toxicology. 34(1). 4–10. 17 indexed citations

Köck, Kathleen, Jason M. Gow, Michelle Horner, et al.. (2014). Preclinical development ofAMG139, a human antibody specifically targetingIL‐23. British Journal of Pharmacology. 172(1). 159–172. 25 indexed citations

Nguyen, Thai, Svetlana Markova, Wanqing Liu, et al.. (2012). Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression. The Pharmacogenomics Journal. 13(5). 396–402. 31 indexed citations

Lowes, David J., Anupam Pradhan, Lalitha Iyer, et al.. (2012). Lead Optimization of Antimalarial Propafenone Analogues. Journal of Medicinal Chemistry. 55(13). 6087–6093. 11 indexed citations

Zhang, Yiqun, Julie Clark, Michele Connelly, et al.. (2012). Lead Optimization of 3-Carboxyl-4(1H)-Quinolones to Deliver Orally Bioavailable Antimalarials. Journal of Medicinal Chemistry. 55(9). 4205–4219. 72 indexed citations

Kelly, Libusha, Hisayo Fukushima, Rachel Karchin, et al.. (2010). Functional hot spots in human ATP‐binding cassette transporter nucleotide binding domains. Protein Science. 19(11). 2110–2121. 13 indexed citations

Hodges, Laura M., Svetlana Markova, Leslie W. Chinn, et al.. (2010). Very important pharmacogene summary. Pharmacogenetics and Genomics. 21(3). 152–161. 341 indexed citations

Gow, Jason M., Laura M. Hodges, Leslie W. Chinn, & Deanna L. Kroetz. (2008). Substrate-Dependent Effects of Human ABCB1 Coding Polymorphisms. Journal of Pharmacology and Experimental Therapeutics. 325(2). 435–442. 48 indexed citations

10.

Chinn, Leslie W., et al.. (2007). Interindividual variability in the effect of atazanavir and saquinavir on the expression of lymphocyte P-glycoprotein. Journal of Antimicrobial Chemotherapy. 60(1). 61–67. 7 indexed citations

11.

Gow, Jason M., Leslie W. Chinn, & Deanna L. Kroetz. (2007). The Effects of ABCB1 3′-Untranslated Region Variants on mRNA Stability. Drug Metabolism and Disposition. 36(1). 10–15. 13 indexed citations

12.

Gow, Jason M., Leslie W. Chinn, Libusha Kelly, et al.. (2006). PharmGKB Submission Update: IV. PMT Submissions of Genetic Variations in ATP-Binding Cassette Transporters to the PharmGKB Network. Pharmacological Reviews. 58(1). 1–2. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact